Sanofi US News

- Sarilumab, Given Subcutaneously Every Other Week, Met All Three Co-Primary Endpoints -

- Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies -

Event Builds on Tradition of Corporate Citizenship and Community

New online resource provides customized tools, resources developed by leading Grandparent Expert to help grandparents learn more about highly contagious, often serious disease

- Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin -

Campaign harnesses positive peer influence and power of social media to help drive flu vaccination among #FLUgitives

-- Addition of Iconic Brand Bolsters U.S. Consumer Healthcare Business --

- Efficacy trial in more than 30,000 older adults meets primary endpoint for superior efficacy -

- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling -

Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide

- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children -

- Largest supplier of influenza vaccine in U.S., first to ship, will distribute more than 60 million doses of flu vaccines for fall immunization campaigns -

- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® -

-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents --

- Headfirst! Expert Advice on Lice Offers Moms and Healthcare Providers Helpful Tools and Resources to Overcome Head Lice -

- "Get in the Game" urges parents to take action and vaccinate against meningococcal disease in advance of the upcoming sports season

New Fluzone® Quadrivalent (Influenza Virus Vaccine):

Campaign Continues to Educate Adults on How to Help Protect Themselves and How to Help Stop the Spread of Pertussis to Infants

- Connect & Coach™ Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes -